Concepedia

Matthew R. Silver

MR

14

Publications

1.4K

Citations

12

H-Index

2004

Active since

Affiliations

Cell Signaling Technology (United States)(Current)

Harvard University

Yale University

Brigham and Women's Hospital

University of New Hampshire

Matthew R. Silver is an author at Cell Signaling Technology (United States) specializing in medicine, immunology, and tumor biology.

Top concepts

Publications per year

2004–2020

14

Publications

14

PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer

Hallie Wimberly, Jason R. Brown, Kurt A. Schalper et al. · Cancer Immunology Research · 2014 · 384 citations · Full text

, , +16

Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non–Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion

Victoria Rimkunas, Katherine E. Crosby, Daiqiang Li et al. · Clinical Cancer Research · 2012 · 291 citations

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100

Markus Moehler, Mikhail Dvorkin, Narikazu Boku et al. · Journal of Clinical Oncology · 2020 · 212 citations · Full text

First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors

Julius Strauss, Christopher R. Heery, Joseph W. Kim et al. · Clinical Cancer Research · 2018 · 164 citations · Full text

IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation

Matthew R. Silver, Alexander R. Margulis, Nancy L. Wood et al. · Inflammation Research · 2009 · 130 citations

, , +12

Rows per page

1–5 of 14